Literatur
-
1
Ellger B, Debaveye Y, Van den Berghe G.
Endocrine interventions in the ICU.
Eur J Intern Med.
2005;
16
71-82
-
2
Van den Berghe G.
Dynamic neuroendocrine responses to critical illness.
Front Neuroendocrinol.
2002;
23
370-391
-
3
Debaveye Y, Van den Berghe G.
Is there still a place for dopamine in the modern intensive care unit?.
Anesth Analg.
2004;
98
461-468
-
4
Kitabchi A E, Umpierrez G E, Murphy M B. et al .
Management of hyperglycemic crises in patients with diabetes.
Diabetes Care.
2001;
24
131-153
-
5
The Diabetes Control and Complications Trial Research Group .
Hypoglycemia in the Diabetes Control and Complications Trial.
Diabetes.
1997;
46
271-286
-
6
Krinsley J S.
Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.
Mayo Clin Proc.
2003;
78
1471-1478
-
7
Van den Berghe G.
How does blood glucose control with insulin save lives in intensive care?.
J Clin Invest.
2004;
114
1187-1195
-
8
Pittas A G, Siegel R D, Lau J.
Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials.
Arch Intern Med.
2004;
164
2005-2011
-
9
Ellger B, Debaveye Y, Vanhorebeek I. et al .
Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
Diabetes.
2006;
55
1096-1105
-
10
Van den Berghe G, Wouters P, Weekers F. et al .
Intensive insulin therapy in the critically ill patients.
N Engl J Med.
2001;
345
1359-1367
-
11
Krinsley J S.
Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.
Mayo Clin Proc.
2004;
79
992-1000
-
12
Van den Berghe G, Wilmer A, Hermans G. et al .
Intensive insulin therapy in the medical ICU.
N Engl J Med.
2006;
354
449-461
-
13
Van den Berghe G, Wilmer A, Milants I. et al .
Intensive Insulin Therapy in Mixed Medical/Surgical intensive Care Units. Benefit versus Harm.
Diabetes.
2006;
55
3151-3160
-
14
Van den Berghe G, Wouters P J, Bouillon R. et al .
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Crit Care Med.
2003;
31
359-366
-
15
Van den Berghe G.
How does blood glucose control with insulin save lives in intensive care?.
J Clin Invest.
2004;
114
1187-1195
-
16
Brunkhorst F M, Engel C, Bloos F. et al .
Intensive Insulin therapy and pentastarch resuscitation in severe sepsis.
N Engl J Med.
2008;
358
125-139
-
17
Ellger B, Westphal M, Stubbe H. et al .
Blutzuckerkontrolle bei Patienten mit Sepsis und septischem Schock – Freund oder Feind?.
Anaesthesist.
2008;
57
43-48
-
18
Dellinger R P, Levy M M, Carlet J M. et al .
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
Crit Care Med.
2008;
36
296-327
-
19
Van den Berghe G, Wouters P, Weekers F. et al .
Intensive insulin therapy in the critically ill patients.
N Engl J Med.
2001;
345
1359-1367
-
20
Van den Berghe G, Wouters P J, Bouillon R. et al .
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Crit Care Med.
2003;
31
359-366
-
21
Van den Berghe G.
How does blood glucose control with insulin save lives in intensive care?.
J Clin Invest.
2004;
114
1187-1195
-
22
Krinsley J S.
Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.
Mayo Clin Proc.
2004;
79
992-1000
-
23
Egi M, Bellomo R, Stachowski E. et al .
Variability of blood glucose and short-term mortality in critically ill patients.
Anesthesiology.
2006;
105
244-252
-
24
Ali N A, O’Brien J M Jr, Dungan K. et al .
Glucose variability and mortality in patients with sepsis.
Crit Care Med.
2008;
-
25
Vogelzang M, Loef B G, Reqtien J G. et al .
Computer-assisted glucose control in critically ill patients.
Intensive Care Med.
2008;
34
1421-1427
-
26
Krinsley J S.
Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.
Mayo Clin Proc.
2004;
79
992-1000
-
27
Van den Berghe G, Wouters P, Weekers F. et al .
Intensive insulin therapy in the critically ill patients.
N Engl J Med.
2001;
345
1359-1367
-
28
Roberts C G, Ladenson P W.
Hypothyroidism.
Lancet.
2004;
363
793-803
-
29
Cooper D S.
Hyperthyroidism.
Lancet.
2003;
362
459-468
-
30
Stathatos N, Levetan C, Burman K D. et al .
The controversy of the treatment of critically ill patients with thyroid hormone.
Best Pract Res Clin Endocrinol Metab.
2001;
15
465-478
-
31
Van den Berghe G, Baxter R C, Weekers F. et al .
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
Clin Endocrinol (Oxf).
2002;
56
655-669
-
32
Takala J, Ruokonen E, Webster N R. et al .
Increased mortality associated with growth hormone treatment in critically ill adults.
N Engl J Med.
1999;
341
785-792
-
33
Van den Berghe G, Baxter R C, Weekers F. et al .
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
Clin Endocrinol (Oxf).
2002;
56
655-669
-
34
Marik P E, Pastores S M, Annane D. et al .
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statement from an international task force by the American College of Critical Care Medicine.
Crit Care Med.
2008;
36
1937-1948
-
35
Annane D, Sebille V, Troche G. et al .
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.
JAMA.
2000;
283
1038-1045
-
36
Peter J V, John P, Graham P L. et al .
Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis.
BMJ.
2008;
336
1006-1009
-
37
Coursin D B, Wood K E.
Corticosteroid supplementation for adrenal insufficiency.
JAMA.
2002;
287
236-240
-
38
Hirshberg E, Larsen G, Van Duker H.
Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity.
Pediatr Crit Care Med.
2008;
9
361-366
-
39
Wintergerst K A, Buckingham B, Gandrud L. et al .
Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit.
Pediatrics.
2006;
118
173-179
-
40
Klein G W, Hojsak J M, Schmeidler J. et al .
Hyperglycemia and outcome in the pediatric intensive care unit.
J Pediatr.
2008;
-
41
Kong M Y, Alten J, Tofil N.
Is hyperglycemia really harmful? A critical appraisal of „Persistent hyperglycemia in critically ill children” by Faustino and Apkon. (J Pediatr 2005; 146: 30 – 34).
Pediatr Crit Care Med.
2007;
8
482-485
-
42
Ross O C, Petros A.
The sick euthyroid syndrome in paediatric cardiac surgery patients.
Intensive Care Med.
2001;
27
1124-1132
-
43
Bettendorf M, Schmidt K G, Grulich-Henn J. et al .
Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study.
Lancet.
2000;
356
529-534
-
44
Sarthi M, Lodha R, Vivekanandhan S. et al .
Adrenal status in children with septic shock using low-dose stimulation test.
Pediatr Crit Care Med.
2007;
8
23-28
-
45
Zimmerman J J.
A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction towards evidence-based medicine.
Pediatr Crit Care Med.
2007;
8
530-539
Dr. Björn Ellger
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster
Albert-Schweitzer-Str. 33
48149 Münster
Email: ellger@anit.uni-muenster.de
